FDA.reportPublic FDA data

84 HR estradiol 0.00104 MG/HR Transdermal System [Vivelle]

RxCUI
284378
RxNorm name
84 HR estradiol 0.00104 MG/HR Transdermal System [Vivelle]
Display name
84 HR estradiol 0.00104 MG/HR Transdermal System [Vivelle]
Full name
84 HR estradiol 0.00104 MG/HR Transdermal System [Vivelle]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
5ccb77f9-d47b-4381-ad5c-5b92524e1c4aVivelle dot 0.025 MG/Day Twice Weekly Transdermal System [PSN] · 84 HR estradiol 0.00104 MG/HR Transdermal System [Vivelle] [SBD] · 84 HR Vivelle 0.00104 MG/HR Transdermal System [SY] · Vivelle 0.025 MG/24HR Twice Weekly Transdermal Patch [SY] · Vivelle dot 0.025 MG/Day Twice Weekly Transdermal System [SY]517These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT. VIVELLE-DOT ® (estradiol transdermal system) Initial U.S. Approval: 199620231117
03ab0226-b494-4607-8e8b-7381082fa780Vivelle dot 0.025 MG/Day Twice Weekly Transdermal System [PSN] · 84 HR estradiol 0.00104 MG/HR Transdermal System [Vivelle] [SBD] · 84 HR Vivelle 0.00104 MG/HR Transdermal System [SY] · Vivelle 0.025 MG/24HR Twice Weekly Transdermal Patch [SY] · Vivelle dot 0.025 MG/Day Twice Weekly Transdermal System [SY]51Vivelle-Dot20120217